Advertisement

Topics

NA | Ribavirin [Aurobindo Pharma Limited] | BioPortfolio

17:37 EST 26th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Ribavirin Tablets

3000 Tablets Batch      : Mfg         : Expiry      : To be repacked within six months from the date of manufacturing NDC 65862-207-39 BULK SHIPMENTPLEASE HANDLE CAREFULLY Rx only Ribavirin Tablets 200 mg Each film-coated tablet contains: Ribavirin USP 200 mg. CAUTION: FOR REPACKAGING ONLY Store at 20º to 25ºC (68º to 77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [see USP Controlled Room Temperature]. Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072, India

Manufacturer

Aurobindo Pharma Limited

Active Ingredients

Source

Drugs and Medications [91 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [aurobindo pharma limited]

NA

Ribavirin [cadila healthcare limited]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES. RIBAVIRIN capsules, for oral use I...

Ribavirin [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES. RIBAVIRIN capsules, for oral useIn...

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Clinical Trials [509 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

The results of antiviral therapy in patients with recurrent hepatitis C after liver transplantation are lower than standard. Ribavirin has immune-modulating effects and seems to be crucial...

A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

To compare the safety, toxicity, and tolerance of two doses of ribavirin in combination with didanosine (ddI) to HIV-infected children. To determine the toxicity of ddI/ribavirin and compa...

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

To determine how fast ribavirin reaches the bloodstream, what concentration of ribavirin is reached in blood and how long it remains in the blood (pharmacokinetics) when given by different...

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523AM2)(COMPLETED)

This is a Phase 2, randomized, 7-arm , open-label safety and efficacy study comparing treatment with PegIntron (1.5 µg/kg QW) plus ribavirin (800-1400 mg/day) to treatment with SCH 503034...

PubMed Articles [67 Associated PubMed Articles listed on BioPortfolio]

Evaluation on the antiviral activity of ribavirin against infectious hematopoietic necrosis virus in epithelioma papulosum cyprini cells.

Infectious hematopoietic necrosis virus (IHNV) causes high mortality in several economically important salmonid fishes, but there is no approved therapy up to now. To address the urgent need for thera...

Tolerability of erythrocyte ribavirin triphosphate concentrations depends on the ITPA genotype.

Ribavirin (RBV) is an antiviral drug that is part of the current standard therapy for chronic hepatitis C (CHC). It is enzymatically converted to ribavirin triphosphate (RTP) that inhibits the activit...

Cost-effectiveness of sofosbuvir plus ribavirin therapy for hepatitis C virus genotype 2 infection in South Korea.

For genotype 2 chronic hepatitis C (CHC), the efficacy and safety of sofosbuvir plus ribavirin therapy (SOF+RBV) was better than pegylated interferon plus ribavirin therapy (PR) at a greater drug cost...

Predictive value of IL-28B rs12979860 variants for peg-IFN, sofosbuvir plus ribavirin treatment of HCV infection in Pakistani population.

The correlation of IL28-B genetic variants (rs12979860) with combinational therapy (peg-interferon, sofosbuvir plus ribavirin) of hepatitis C virus infection were studied in 154 chronic hepatitis C pa...

Transport of ribavirin across the rat and human placental barrier: roles of nucleoside and ATP-binding cassette drug efflux transporters.

Ribavirin is a broad-spectrum nucleoside-derived antiviral drug used in combination pharmacotherapy treatment of hepatitis C virus infection. Current evidence indicates that ribavirin-associated terat...

Advertisement
Quick Search
Advertisement
Advertisement

 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record